BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6897239)

  • 1. Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia.
    Weller RE; Theilen GH; Madewell BR
    J Am Vet Med Assoc; 1982 Nov; 181(9):891-3. PubMed ID: 6897239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic combination chemotherapy of canine lymphosarcoma.
    MacEwen EG; Brown NO; Patnaik AK; Hayes AA; Passe S
    J Am Vet Med Assoc; 1981 Jun; 178(11):1178-81. PubMed ID: 6895078
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
    MacEwen EG; Hayes AA; Matus RE; Kurzman I
    J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma.
    MacEwen EG; Hayes AA; Mooney S; Patnaik A; Kurzman I; Hardy WD
    J Biol Response Mod; 1985 Aug; 4(4):427-33. PubMed ID: 3839843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for canine lymphosarcoma.
    Madewell BR
    Am J Vet Res; 1975 Oct; 36(10):1525-8. PubMed ID: 1242622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carmustine, vincristine, and prednisone in the treatment of canine lymphosarcoma.
    Ricci Lucas SR; Pereira Coelho BM; Marquezi ML; Franchini ML; Miyashiro SI; De Benedetto Pozzi DH
    J Am Anim Hosp Assoc; 2004; 40(4):292-9. PubMed ID: 15238559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with vincristine, cyclophosphamide, and prednisone producing long-term remission of a transplanted canine lymphoma.
    Cohen H; Schmidt CE; Lucas SR; Palmer JL
    Am J Vet Res; 1975 Oct; 36(10):1483-7. PubMed ID: 1238040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid and phosphorus excretion in dogs with lymphosarcoma.
    Page RL; Leifer CE; Matus RE
    Am J Vet Res; 1986 Apr; 47(4):910-2. PubMed ID: 3754406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
    Marconato L; Bonfanti U; Stefanello D; Lorenzo MR; Romanelli G; Comazzi S; Zini E
    Vet Comp Oncol; 2008 Jun; 6(2):80-9. PubMed ID: 19178667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoimmunotherapy for canine lymphosarcoma.
    Theilen GH; Worley M; Benjamini E
    J Am Vet Med Assoc; 1977 Mar; 170(6):607-10. PubMed ID: 576595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic classification as a prognostic criterion for canine lymphosarcoma.
    Weller RE; Holmberg CA; Theilen GH; Madewell BR
    Am J Vet Res; 1980 Aug; 41(8):1310-4. PubMed ID: 6893792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combination l-asparaginase plus CHOP or modified MOPP treatment protocols in dogs with multi-centric T-cell or hypercalcaemic lymphoma.
    Angelo G; Cronin K; Keys D
    J Small Anim Pract; 2019 Jul; 60(7):430-437. PubMed ID: 30790291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs.
    Zarfoss M; Schatzberg S; Venator K; Cutter-Schatzberg K; Cuddon P; Pintar J; Weinkle T; Scarlett J; Delahunta A
    J Small Anim Pract; 2006 Oct; 47(10):588-95. PubMed ID: 17004951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
    Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hypercalcemia in a dog with lymphosarcoma.
    Weller RE; Melcon D
    Mod Vet Pract; 1978 Dec; 59(12):901-3. PubMed ID: 581606
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoimmunotherapy for canine lymphosarcoma: a prospective evaluation of specific and nonspecific immunomodulation.
    Weller RE; Theilen GH; Madewell BR; Crow SE; Benjamini E; Villalobos A
    Am J Vet Res; 1980 Apr; 41(4):516-21. PubMed ID: 6893260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lymphoblastic leukemia in the dog: a review of 30 cases.
    Matus RE; Leifer CE; MacEwen EG
    J Am Vet Med Assoc; 1983 Oct; 183(8):859-62. PubMed ID: 6579048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone changes in hypercalcemia of malignancy in dogs.
    Norrdin RW; Powers BE
    J Am Vet Med Assoc; 1983 Aug; 183(4):441-4. PubMed ID: 6688616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.